Article
Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Jan 2019
Wojas-Krawczyk Kamila, Kalinka-Warzocha Ewa, Reszka Katarzyna, Nicoś Marcin, Szumiło Justyna, Mańdziuk Sławomir, Szczepaniak Katarzyna, Kupnicka Dorota, Lewandowski Remigiusz, Milanowski Janusz, Krawczyk Paweł
Abstract excerpt
BACKGROUND: Colorectal cancer (CRC) is usually diagnosed in the metastatic stage, when chemotherapy and molecularly-targeted therapies, instead of surgery, play the most important therapeutic role. Application of anti-epidermal growth factor receptor (EGFR) therapy requires the analysis of RAS mutation status and only RAS wild-type (wt) patients are qualified for the therapy. OBJECTIVES: The objective of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
